E Ivan
Overview
Explore the profile of E Ivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ngabonziza J, Habimana Y, Decroo T, Migambi P, Dushime A, Mazarati J, et al.
Int J Tuberc Lung Dis
. 2020 Apr;
24(3):329-339.
PMID: 32228764
In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin drug...
2.
Bryce T, Biering-Sorensen F, Finnerup N, Cardenas D, Defrin R, Ivan E, et al.
Spinal Cord
. 2012 Feb;
50(6):404-12.
PMID: 22310319
Study Design: International validation study using self-administered surveys. Objectives: To investigate the utility and reliability of the International Spinal Cord Injury Pain (ISCIP) Classification as used by clinicians. Methods: Seventy-five...
3.
Platica M, Ivan E, Chen S, HOLLAND J, Gil J, Mandeli J, et al.
Prostate
. 2001 Dec;
49(3):200-7.
PMID: 11746265
Background: PAR is a novel gene ubiquitously expressed in normal and malignant tissues with a trend towards higher expression in tumor cells. PAR biological function is unknown. Here we report...
4.
Platica O, Chen S, Ivan E, Lopingco M, HOLLAND J, Platica M
Int J Oncol
. 2000 Apr;
16(5):1055-61.
PMID: 10762645
During our work on the mechanism of hormone resistance of prostatic carcinomas, a novel gene that we called PAR (prostate androgen regulated) was isolated from an androgen resistant subline (LNCaP-OM)...
5.
Godin D, Ivan E, JOHNSON C, Magid R, Galis Z
Circulation
. 2000 Jan;
102(23):2861-6.
PMID: 11104745
Background: The matrix-degrading activity of matrix metalloproteinases (MMPs), required for cell migration and general tissue reshaping, is thought essential for pathological arterial remodeling in atherosclerosis and restenosis. Methods And Results:...
6.
Ivan E, Bodrogligeti I, JUHASZ-NAGY A, Nemet L, CHOLNOKY E
Arch Toxicol Suppl
. 1985 Jan;
8:495-8.
PMID: 3868381
Differentiation of T-lymphocytes is regulated by thymopoietin, a 49 amino acid polypeptide chain. The site of immunological activity is in the 32-36 (Arg-Lys-Asp-Val-Tyr) fragment. This pentapeptide can be reduced to...
7.
Bencz Z, Ivan E, CHOLNOKY E
Arch Toxicol Suppl
. 1985 Jan;
8:476-9.
PMID: 3868378
RGH-6201 (4-diethylaminoethoxy-alpha-ethyl-benzhydrol) in the first dose-range finding study on rats produced severe, irreversible ophthalmic damage. The underlying mechanism was studied in a series of experiments with daily doses of 50,...
8.
Bacsy E, Ivan E, duc Moi V, RAPPAY G
Histochemistry
. 1983 Jan;
78(2):231-9.
PMID: 6307936
E600 resistant non-specific esterase activity or acid phosphatase activity were localized in corticotrophic cells identified by postembedding immunocytochemistry (PAP of protein A-immunogold techniques). The lysosomal system of this cell type...
9.
Nau H, Steldinger R, Ivan E
Eur J Clin Pharmacol
. 1982 Jan;
23(3):253-60.
PMID: 7173295
The placental transfer of etozolin and its pharmacologically active metabolite ozolinone was studied in 48 patients during the first (44 patients) and second (4 patients) trimester. 24 patients received a...
10.
Ivan E, Ene A
Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit
. 1980 Sep;
28(9):195-8.
PMID: 6777983
No abstract available.